Bare Financial Services’s Soleno Therapeutics SLNO Stock Holding History

Bare Financial Services’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10	Closed	-$335	–	1902
2026 Q1	$335	Sell	10 -13	-57%	-$510	﹤0.01%	1702
2025 Q4	$1.06K	Buy	+23	New	+$1.26K	﹤0.01%	1108

Bare Financial Services's SLNO Position: Q2 2026 in Review

Bare Financial Services sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 10 shares — an estimated $335 sold.

Bare Financial Services first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $1.06K in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Bare Financial Services reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Bare Financial Services sold 10 Soleno Therapeutics shares in Q2 2026, an estimated $335.
Bare Financial Services first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
Bare Financial Services's Soleno Therapeutics position peaked at $1.06K in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.